Join
Live feed
·
NEWSReleasevia Quantisnow
Entero Therapeutics Inc. logo

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

ByQuantisnow·Wall Street's wire, on your screen.
ENTO· Entero Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTO (Entero Therapeutics Inc.) and more on Quantisnow.